1. Home
  2. RMT vs OMER Comparison

RMT vs OMER Comparison

Compare RMT & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Micro-Cap Trust Inc.

RMT

Royce Micro-Cap Trust Inc.

N/A

Current Price

$13.23

Market Cap

771.7M

Sector

Finance

ML Signal

N/A

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$17.60

Market Cap

844.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMT
OMER
Founded
1993
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
771.7M
844.6M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
RMT
OMER
Price
$13.23
$17.60
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
104.9K
1.5M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
7.37%
N/A
EPS Growth
N/A
98.15
EPS
1.49
0.77
Revenue
N/A
$29,868,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$233.22
P/E Ratio
$8.85
$22.30
Revenue Growth
N/A
N/A
52 Week Low
$9.52
$3.94
52 Week High
$14.78
$19.65

Technical Indicators

Market Signals
Indicator
RMT
OMER
Relative Strength Index (RSI) 29.40 49.27
Support Level $12.88 $10.16
Resistance Level $13.38 $17.65
Average True Range (ATR) 0.21 0.82
MACD -0.09 -0.45
Stochastic Oscillator 0.00 21.47

Price Performance

Historical Comparison
RMT
OMER

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector, including diversified consumer services, hotels, household durables, leisure products, and luxury goods. Consumer staples sector, including beverages, food, and staples retailing, food products, and personal products, Energy sector, including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors, including healthcare, financials, industrials, IT, telecommunications, and materials.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: